OHR Pharmaceutical Inc.

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
01/03/19 8-K Current report filing 173
01/03/19 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions 173
01/03/19 10-K Annual report pursuant to Section 13 and 15(d) 83
12/31/18 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT 3
12/18/18 DEF 14A Definitive proxy statements 25
12/07/18 PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition 25
10/04/18 8-K Current report filing 3
09/07/18 DEF 14A Definitive proxy statements 33
08/29/18 8-K Current report filing 3
08/23/18 8-K Current report filing 3